• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 439013 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414845642 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414845642 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

EnteroMedics Down 56.0%, Shares Slide into the Red (ETRM)

Published on Fri, 02/08/2013 - 11:23
By Robert Cotter

EnteroMedics (NASDAQ:ETRM) is one of today's worst performing low-priced stocks, down 56.0% to $1.25 on 19.4x average daily volume. EnteroMedics has traded 8.6 million shares thus far today, vs. average volume of 444,000 shares per day. The stock has underperformed the Dow (-56.0% to the Dow's 0.4%) and underperformed the S&P 500 (-56.0% to the S&P's 0.5%) during today's trading.

EnteroMedics share prices have moved between a 52-week high of $4.40 and the current low of $1.19 and are currently at $1.25 per share. The 200-day and 50-day moving averages have moved 0.28% higher and 0.38% lower over the past week, respectively.

EnteroMedics has overhead space with shares priced $1.25, or 71.4% below the average consensus analyst price target of $4.38. The stock should find initial resistance at its 50-day moving average (MA) of $2.72 and further resistance at its 200-day MA of $3.18.

EnteroMedics Inc. is a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Zimmer Looks to Continue to Trade Above ...

Shares of Zimmer (NYSE:ZMH) traded today at $111.21, breaking its 52-week high. This n ...

Shares of Yahoo! Rise to a New 52-Week H...

Yahoo! (NASDAQ:YHOO) traded at a new 52-week high today of $46.52. So far today approx ...

Shares of Aqua America Rise to a New 52-...

Shares of Aqua America (NYSE:WTR) traded at a new 52-week high today of $26.42. This n ...

West Pharmaceutical Services: 52-Week Hi...

Shares of West Pharmaceutical Services (NYSE:WST) traded today at $51.63, breaking its ...

Recent 52-Week High Exceeded in Shares o...

Shares of WesBanco (NASDAQ:WSBC) traded at a new 52-week high today of $34.94. This ne ...

Recent 52-Week High Exceeded in Shares o...

Weingarten Realty Investors (NYSE:WRI) traded at a new 52-week high today of $36.02. S ...

Shares of WR Berkley Rise to a New 52-We...

WR Berkley (NYSE:WRB) traded today at a new 52-week high of $51.63. This new high was ...

VCA Antech: 52-Week High Recently Eclips...

Shares of VCA Antech (NASDAQ:WOOF) traded at a new 52-week high today of $45.94. So fa ...